Transplanted Cerebrospinal Fluid-Contacting Neurons Alleviate Spasticity Following Spinal Cord Injury in Mice

Area of Science:

• Neuroscience
• Regenerative Medicine
• Stem Cell Biology

Background:

• Spasticity is a debilitating condition following spinal cord injury (SCI) with limited therapeutic options.
• Replacing lost GABAergic neurons via stem cell transplantation is a potential treatment strategy.
• Cerebrospinal fluid-contacting neurons (CSF-cNs) possess stem cell characteristics and can differentiate into GABAergic neurons.

Purpose of the Study:

• To investigate the survival and differentiation of transplanted CSF-cNs in the SCI microenvironment.
• To evaluate the efficacy of CSF-cN transplantation in alleviating spasticity post-SCI.
• To explore the potential of CSF-cNs as a therapeutic agent for SCI-induced spasticity.

Main Methods:

• Isolation and in vitro differentiation of CSF-cNs from adult mice.
• Transplantation of CSF-cNs into the injured spinal cord area one week post-SCI.
• Assessment of cell survival, differentiation, and spasticity using immunofluorescence, electrophysiology, and gait analysis.

Main Results:

• Transplanted CSF-cNs survived and differentiated into GABAergic neurons (expressing NeuN, GABA, GAD65/67, VGAT).
• Significant improvement in hindlimb grasp reflex scores within three weeks post-transplantation.
• Marked alleviation of spasticity, evidenced by superior H-reflex rate-dependent depression and improved gait parameters (stride length, step width, coordination) at 6 and 12 weeks.

Conclusions:

• Transplanted CSF-cNs successfully integrate and differentiate into functional GABAergic neurons in the SCI context.
• CSF-cN transplantation provides significant symptomatic relief from spasticity following SCI in mice.
• CSF-cN transplantation is a viable strategy for alleviating spasticity, though further research into mechanisms and complete recovery is warranted.